Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

NBY Relative to the S&P 500

NBY Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the NovaBay Pharmaceuticals, Inc. (AMEX:NBY) seasonal charts above shows that a Buy Date of December 25 and a Sell Date of March 25 has resulted in a geometric average return of 4.41% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 104.41% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically?eyecare and skincare products. Its?product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is?laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

To download NBY seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: NBY